Efficacy of mirtazapine in preventing delayed nausea and vomiting induced by highly emetogenic chemotherapy: An open-label, randomized, multicenter phase III trial.

被引：2
|
作者：
Cao, Jun
Wang, Biyun
Wang, Zhonghua
Zhang, Jian
Wang, Leiping
Cao, Enying
Zhao, Yannan
Feng, Zhe
Ouyang, Quchang
Wang, Shusen
Hu, Xichun
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Hu Nan Tumor Hosp, Changsha, Hunan, Peoples R China
[3] Canc Hosp Zhongshan Med, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.1078
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1078
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)
    Hisanori Shimizu
    Kenichi Suzuki
    Takeshi Uchikura
    Daiki Tsuji
    Takeharu Yamanaka
    Hironobu Hashimoto
    Koichi Goto
    Reiko Matsui
    Nobuhiko Seki
    Toshikazu Shimada
    Shunya Ikeda
    Naoki Ikegami
    Toshihiro Hama
    Nobuyuki Yamamoto
    Tadanori Sasaki
    [J]. Journal of Pharmaceutical Health Care and Sciences, 4 (1)
  • [32] Efficacy and safety of fosaprepitant in the prevention of nausea and vomiting following highly emetogenic chemotherapy in Chinese people: A randomized, double-blind, phase III study
    Yang, L. Q.
    Sun, X. C.
    Qin, S. K.
    Cheng, Y.
    Shi, J. H.
    Chen, Z. D.
    Wang, Q. M.
    Zhang, H. L.
    Hu, B.
    Liu, B.
    Zhang, Q. Y.
    Wu, Q.
    Wang, D.
    Shu, Y. Q.
    Dong, J.
    Han, B. H.
    Wang, K. M.
    Dang, C. X.
    Li, J. L.
    Wang, H. B.
    Li, B. L.
    Lu, J. G.
    Zhang, Z. H.
    Chen, Y. X.
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (06)
  • [33] Olanzapine versus Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting: A Randomized Phase III Trial
    Navari, R.
    Gray, S.
    Kerr, A.
    [J]. PSYCHO-ONCOLOGY, 2012, 21 : 111 - 112
  • [34] Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study
    Iihara, Hirotoshi
    Shimokawa, Mototsugu
    Bando, Hiroko
    Niwa, Yoshimi
    Mizuno, Yutaka
    Kawaguchi, Yoshihiro
    Kitahora, Mika
    Murakami, Akari
    Kawai, Masaaki
    Ishida, Kazushige
    Takeuchi, Makoto
    Ishihara, Kazuhiro
    Iyoda, Tomokazu
    Nakada, Takumi
    Ogiso, Atsuko
    Kojima, Yasuyuki
    Kumagai, Fumiyoshi
    Sawa, Aya
    Mori, Ryutaro
    Higuchi, Kosuke
    Furuta, Tomoko
    Kamei, Yoshiaki
    Tsuchiya, Masami
    Terasaki, Azusa
    Yamamoto, Senri
    Kitazawa, Mai
    Okazaki, Mai
    Suzuki, Akio
    Futamura, Manabu
    [J]. JOURNAL OF CANCER, 2023, 14 (14): : 2644 - 2654
  • [35] Granisetron vs dolasetron for acute chemotherapy-induced nausea and vomiting (CINV) in high and moderately high emetogenic chemotherapy: an open-label pilot study
    Tan, M
    Xu, R
    Seth, R
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (06) : 879 - 882
  • [36] Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer
    Murakami, Michiyasu
    Hashimoto, Hiroki
    Yamaguchi, Kyohei
    Yamaguchi, Ikuko
    Senba, Shozo
    Siraishi, Takeshi
    [J]. SUPPORTIVE CARE IN CANCER, 2014, 22 (04) : 905 - 909
  • [37] Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer
    Michiyasu Murakami
    Hiroki Hashimoto
    Kyohei Yamaguchi
    Ikuko Yamaguchi
    Shozo Senba
    Takeshi Siraishi
    [J]. Supportive Care in Cancer, 2014, 22 : 905 - 909
  • [38] A randomized, open-label, multicenter trial of immediate versus delayed intervention with darbepoetin alfa for chemotherapy-induced anemia
    Charu, Veena
    Saidman, Bruce
    Ben-Jacob, Ali
    Justice, Glen R.
    Maniam, Ajit S.
    Tomita, Dianne
    Rossi, Greg
    Rearden, Timothy
    Glaspy, John
    [J]. ONCOLOGIST, 2007, 12 (10): : 1253 - 1263
  • [39] Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE
    Hata, Akito
    Okamoto, Isamu
    Inui, Naoki
    Okada, Morihito
    Morise, Masahiro
    Akiyoshi, Kohei
    Takeda, Masayuki
    Watanabe, Yasutaka
    Sugawara, Shunichi
    Shinagawa, Naofumi
    Kubota, Kaoru
    Saeki, Toshiaki
    Tamura, Tomohide
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (02) : 180 - +
  • [40] Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy
    Boccia, Ralph
    O'Boyle, Erin
    Cooper, William
    [J]. BMC CANCER, 2016, 16
12345